Investors
Newsroom
Responsibility
Subscribe
Abbott Header Logo

Press Releases
Get News Alerts by Email
Advanced Search
  • Jan 26, 2022
    Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
    - Fourth-quarter sales growth of 7.2 percent; organic sales growth of 7.7 percent
    - Global COVID-19 testing-related sales of $2.3 billion in the fourth quarter
    - Excluding COVID-19 testing-related sales, fourth-quarter sales growth of 9.6 percent and organic sales growth of 10.3 percent
    - Full-year 2021 sales growth of 24.5 percent; organic sales growth of 22.9 percent
    - Full-year 2021 GAAP diluted EPS from continuing operations growth of 58.2 percent; adjusted diluted EPS growth of 42.7 percent
    - R&D pipeline continues to deliver a steady cadence of new products, including several in large, fast-growing markets
  • Jan 4, 2022
    Abbott Hosts Conference Call for Fourth-Quarter Earnings
Show 5102550100 per page

YOU ARE ABOUT TO EXIT FOR ANOTHER ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

DO YOU WISH TO CONTINUE AND EXIT THIS WEBSITE?